Apple beats estimates on strong iPhone sales
Digest more
CNBC’s Fast Money panel recently made a notable pivot on its April 24 episode, arguing that Novo Nordisk (NYSE:NVO) now offers a more compelling setup than GLP-1 category leader Eli Lilly (NYSE:LLY) after a peak-to-current decline of roughly 68% from Novo’s mid-2024 high near $127 to recent levels near $40.
1don MSN
'Fast Money' traders talk Meta shares sliding after miss on Q1 DAP, increased capex spending
CNBC;s Julia Boorstin and the 'Fast Money' traders talk Meta shares sliding after miss on Q1 DAP and increased capex spending.